tiprankstipranks
Trending News
More News >
Beam Therapeutics (BEAM)
NASDAQ:BEAM
US Market
Advertisement

Beam Therapeutics (BEAM) Technical Analysis

Compare
2,057 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
2Neutral
5Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Beam Therapeutics’s (BEAM) Moving Averages Convergence Divergence (MACD) indicator is -0.32, suggesting Beam Therapeutics is a Sell.
Beam Therapeutics’s (BEAM) 20-Day exponential moving average is 23.25, while Beam Therapeutics’s (BEAM) share price is $25.03, making it a Buy.
Beam Therapeutics’s (BEAM) 50-Day exponential moving average is 23.33, while Beam Therapeutics’s (BEAM) share price is $25.03, making it a Buy.

Beam Therapeutics (BEAM) Pivot Points

Nov 28, 2025, 08:04 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
21.68
22.50
23.60
24.42
25.52
26.34
27.44
Fibonacci
22.50
23.24
23.69
24.42
25.16
25.61
26.34
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Beam Therapeutics (BEAM) Moving Averages

Nov 28, 2025, 08:04 PM
Period
Simple
Exponential
MA5
23.23Buy
23.73Buy
MA10
22.45Buy
23.12Buy
MA20
22.73Buy
23.25Buy
MA50
24.60Buy
23.33Buy
MA100
21.91Buy
22.57Buy
MA200
21.21Buy
22.76Buy
Beam Therapeutics’s (BEAM) 10-Day exponential moving average is 23.12, while Beam Therapeutics’s (BEAM) share price is $25.03, making it a Buy.
Beam Therapeutics’s (BEAM) 100-Day exponential moving average is 22.57, while Beam Therapeutics’s (BEAM) share price is $25.03, making it a Buy.
Beam Therapeutics’s (BEAM) stock price is $25.03 and Beam Therapeutics’s (BEAM) 50-day simple moving average is 24.60, creating a Buy signal.
Beam Therapeutics’s (BEAM) stock price is $25.03 and Beam Therapeutics’s (BEAM) 100-day simple moving average is 21.91, creating a Buy signal.
Beam Therapeutics’s (BEAM) stock price is $25.03 and Beam Therapeutics’s (BEAM) 200-day simple moving average is 21.21, creating a Buy signal.

Beam Therapeutics (BEAM) Technical Indicators

Nov 28, 2025, 08:04 PM
Name
Value
Implied Action
RSI (14)
57.82
Neutral
STOCH (9,6)
90.77
Sell
STOCHRSI (14)
90.77
Sell
MACD (12,26)
-0.32
Sell
ADX (14)
14.39
Buy
Williams %R
-4.57
Sell
CCI (14)
142.30
Sell
ATR (14)
1.73
-
Ultimate Oscillator
52.31
Neutral
ROC
8.12
Buy
Beam Therapeutics’s (BEAM) Relative Strength Index (RSI) is 57.82, creating a Neutral signal.
Beam Therapeutics’s (BEAM) Trend Strength Indicator (ADX) is 14.39, creating a Buy signal.
Beam Therapeutics’s (BEAM) Commodity Channel Index (CCI) is 142.30, creating a Sell signal.
Beam Therapeutics’s (BEAM) Price Rate of Change (ROC) is 8.12, creating a Buy signal.

FAQ

Is BEAM a Buy, Hold, or Sell?
Based on BEAM’s technical indicators, BEAM is a Buy.
    What is BEAM’s RSI (14)?
    BEAM’s RSI (14) is 57.82, which suggests BEAM is a Neutral.
      What is BEAM’s MACD?
      BEAM’s MACD is -0.32, which suggests BEAM is a Sell.
        What is BEAM’s 5-day moving average?
        BEAM’s 5-day moving average is 23.23, which suggests BEAM is a Buy.
          What is BEAM’s 20-day moving average?
          BEAM 20-day moving average is 22.73, which suggests BEAM is a Buy.
            What is BEAM’s 50-day moving average?
            BEAM’s 50-day moving average is 24.60, which suggests BEAM is a Buy.
              What is BEAM’s 200-day moving average?
              BEAM’s 200-day moving average is 21.21, which suggests BEAM is a Buy.
                What is BEAM’s Williams % R (14)?
                BEAM’s Williams % R (14) is -4.57, which suggests BEAM is a Sell.
                  What is BEAM’s CCI (14)?
                  BEAM’s CCI (14) is 142.30, which suggests BEAM is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis